Ezd-311 ((link))

To mitigate dust-ignition hazards in enclosed spaces.

EZD-311 is a promising candidate in the next generation of targeted oncology therapies. By inhibiting the WEE1 kinase and disrupting the DNA damage response, it offers a potential therapeutic avenue for patients with aggressive and treatment-resistant solid tumors. While further large-scale clinical trials are necessary to fully establish its clinical benefits, EZD-311 highlights the ongoing evolution of precision medicine in oncology. ezd-311